Top Markets
#1 Black Phoenix Black Phoenix +826.33%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.37%
#3 Beam Beam +24.43%
#4 Tutorial Tutorial +24.41%
#5 SAFEcoin SAFEcoin +20.66%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +19.16%
#7 Bless Bless +18.37%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +15.35%
#9 THORChain THORChain +15.06%
#10 EfficientFrontier EfficientFrontier +14.37%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
RayzeBio, Inc. Common Stock RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock

RYZB
Classifica tra le azioni #5676
RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs)... RayzeBio, Inc. is dedicated to creating radiopharmaceutical therapies (RPTs) for oncology applications. Its primary therapeutic candidate, RYZ101, is currently advancing through Phase 3 clinical trials for the management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The company's innovative pipeline also features RYZ801, a distinct peptide engineered to deliver Actinium-225 (Ac225) by targeting GPC3, intended for treating hepatocellular carcinoma (HCC). Additionally, RayzeBio is developing RYZ811, a companion diagnostic imaging agent comprising a peptide binder, a chelator, and Gallium-68 (Ga68). Another active development program involves a novel proprietary small molecule designed to target CA9, delivering Ac225 for potential use against clear cell renal cell carcinoma (ccRCC). The firm was established in 2020 and is headquartered in San Diego, California.
Prezzo delle azioni
$62.49
Ultima sincronizzazione: 2024-03-06
Capitalizzazione di mercato
$2.52B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia RayzeBio, Inc. Common Stock (RYZB)

Categoria

Healthcare
Storico del rendimento da dividendi per RayzeBio, Inc. Common Stock (RYZB)
Il rendimento da dividendi (TTM) di RayzeBio, Inc. Common Stock (simbolo azionario: RYZB) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per RayzeBio, Inc. Common Stock (RYZB) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH